Mangalam Drugs & Organics has informed about Unaudited Financial Results for the quarter and half year ended 30th September, 2017 along with Limited Review Report and the Statement of Assets & Liabilities of the said period in the prescribed form which have been taken on record and approved by the Board of Directors.
The above information is a part of company’s filings submitted to BSE.